​

Hims & Hers Health (HIMS) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

HIMS Stock Forecast

Hims & Hers Health (HIMS) stock forecast, based on 20 Wall Street analysts, predicts a 12-month average price target of $32.17, with a high of $42.00 and a low of $24.50. This represents a 15.30% increase from the last price of $27.90.

$5 $13 $21 $29 $37 $45 High: $42 Avg: $32.17 Low: $24.5 Last Closed Price: $27.9

HIMS Stock Rating

Hims & Hers Health stock's rating consensus is Hold, based on 20 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 7 Buy (35.00%), 13 Hold (65.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Hold
Total 20 0 13 7 Strong Sell Sell Hold Buy Strong Buy

HIMS Price Target Upside V Benchmarks

TypeNameUpside
StockHims & Hers Health15.30%
SectorHealthcare Stocks 15.45%
IndustryMedical Care Facilities Stocks15.54%

Price Target Trends

1M3M12M
# Anlaysts2834
Avg Price Target$33.50$34.88$31.99
Last Closing Price$27.90$27.90$27.90
Upside/Downside20.07%25.02%14.66%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Sep, 262111-115
Aug, 262112--15
Jul, 262111-115
Jun, 263112--16
May, 263111-116
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 24, 2026Truist Financial$32.00$31.252.40%14.70%
Aug 20, 2026Glen SantangeloBarclays$35.00$32.836.61%25.45%
Aug 11, 2026George HillDeutsche Bank$26.00$31.23-16.75%-6.81%
Aug 11, 2026Ryan MacDonaldNeedham$42.00$31.7732.20%50.54%
Aug 11, 2026Morgan Stanley$28.00$31.77-11.87%0.36%
Jul 09, 2026UBS$37.00$36.072.58%32.62%
Jul 01, 2026Canaccord Genuity$40.00$34.6715.37%43.37%
Jun 17, 2026Barclays$39.00$31.8922.30%39.78%
Jun 02, 2026Michael ChernyLeerink Partners$25.00$27.64-9.55%-10.39%
May 26, 2026UBS$25.00$23.755.26%-10.39%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 02, 2026KeyBancSector WeightSector Weighthold
Aug 20, 2026BarclaysOverweightOverweighthold
Aug 11, 2026Deutsche BankHoldHoldhold
Aug 11, 2026Cowen & Co.HoldHoldhold
Aug 11, 2026NeedhamBuyBuyhold
Aug 11, 2026Evercore ISIOutperformOutperformhold
Jul 23, 2026CitigroupNeutralNeutralhold
Jul 09, 2026Bank of America SecuritiesNeutralNeutralhold
Jun 17, 2026BarclaysOverweightOverweighthold
May 26, 2026UBSNeutralNeutralhold

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.58$-0.32$-0.11$0.58$0.57---
Avg Forecast$-0.36$-0.32$-0.13$0.54$0.52$0.72$0.84$0.56
High Forecast$-0.34$-0.28$-0.11$0.58$0.70$0.98$1.19$0.62
Low Forecast$-0.40$-0.35$-0.15$0.50$0.28$0.39$0.45$0.46
Surprise %61.11%--15.38%7.41%9.62%---

Revenue Forecast

$0 $700M $1B $2B $3B $4B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$271.88M$526.92M$872.00M$1.48B$2.35B---
Avg Forecast$264.20M$520.90M$871.89M$1.46B$2.04B$2.35B$2.74B$2.83B
High Forecast$282.12M$557.08M$872.88M$1.47B$2.21B$2.36B$2.78B$3.06B
Low Forecast$249.87M$469.87M$870.58M$1.45B$1.78B$2.34B$2.70B$2.46B
Surprise %2.90%1.15%0.01%1.12%14.84%---

Net Income Forecast

$-150M $-70M $10M $90M $170M $250M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-107.66M$-65.68M$-23.55M$126.04M$128.37M---
Avg Forecast$-108.55M$-67.50M$-23.55M$113.41M$120.85M$172.21M$238.96M$117.23M
High Forecast$-86.84M$-58.90M$-18.84M$121.66M$146.94M$204.73M$248.44M$129.47M
Low Forecast$-130.26M$-73.59M$-28.26M$105.16M$58.78M$81.25M$94.80M$97.17M
Surprise %-0.82%-2.69%-11.14%6.22%---

HIMS Forecast FAQ

Is Hims & Hers Health stock a buy?

Hims & Hers Health stock has a consensus rating of Hold, based on 20 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 7 Buy, 13 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Hims & Hers Health is a neutral investment for most analysts.

What is Hims & Hers Health's price target?

Hims & Hers Health's price target, set by 20 Wall Street analysts, averages $32.17 over the next 12 months. The price target range spans from $24.5 at the low end to $42 at the high end, suggesting a potential 15.30% change from the previous closing price of $27.9.

How does Hims & Hers Health stock forecast compare to its benchmarks?

Hims & Hers Health's stock forecast shows a 15.30% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical care facilities stocks industry (15.54%).

What is the breakdown of analyst ratings for Hims & Hers Health over the past three months?

  • September 2026: 13.33% Strong Buy, 6.67% Buy, 73.33% Hold, 0% Sell, 6.67% Strong Sell.
  • August 2026: 13.33% Strong Buy, 6.67% Buy, 80.00% Hold, 0% Sell, 0% Strong Sell.
  • July 2026: 13.33% Strong Buy, 6.67% Buy, 73.33% Hold, 0% Sell, 6.67% Strong Sell.

What is Hims & Hers Health’s EPS forecast?

Hims & Hers Health's average annual EPS forecast for its fiscal year ending in December 2026 is $0.72, marking a 26.32% increase from the reported $0.57 in 2025. Estimates for the following years are $0.84 in 2027, and $0.56 in 2028.

What is Hims & Hers Health’s revenue forecast?

Hims & Hers Health's average annual revenue forecast for its fiscal year ending in December 2026 is $2.35B, reflecting a -0.00% decrease from the reported $2.35B in 2025. The forecast for 2027 is $2.74B, and $2.83B for 2028.

What is Hims & Hers Health’s net income forecast?

Hims & Hers Health's net income forecast for the fiscal year ending in December 2026 stands at $172.21M, representing an 34.15% increase from the reported $128.36M in 2025. Projections indicate $238.96M in 2027, and $117.23M in 2028.